Carolinas Research Associates is a Clinical Trials Management Organization located in Charlotte, North Carolina. We have developed a unique alliance with private practice physicians in a variety of therapeutic areas. Our commitment is to provide the highest quality, most efficient clinical studies possible to our clients and our research volunteers. CRA will provide the study coordination and management necessary to assure the timely completion of your study.

Our approach to clinical research is centered on the following key standards:

• Experienced Management Staff
• Professional Trained CCRCs
• Experienced Board Certified Investigators
• Accurate CRF Completion
• Complete Regulatory Compliance
• Professionally Developed Corporate SOPs
• Internal Quality Assurance Controls
• Effective Study Volunteer Recruitment
• Thorough Screening and Consenting of Patients
• Rapid, Responsive Communications
• Development of Site-Based Marketing Materials
• Complete Database Management of Studies
• All Coordinators are ACRP Members

The founding partners of Carolinas Research Associates have combined 20 years of medical management and clinical research experience to provide you with expertise in research services. CRA handles everything from regulatory documents through study close-outs. Our major areas of research are with Phase II, III, and IV clinical trials. Major therapeutic areas include: Gastroenterology, Internal Medicine, Neurology, Oncology, and Urology.

Sponsors we have worked with include: Abbott, Astra Merck, Bayer, Biovail, Bristol-Myers Squibb, Covance, Dupont Pharmaceutical, Eli Lilly, Genentech, Glaxo Wellcome, Hoffman LaRoche, Kendle International, Merck, Nexmed, Novartis, Paragon, Parke-Davis, Pfizer, PharmaNet, Phoenix International, Proctor & Gamble, RW Johnson, Quintiles, SmithKline Beecham, TAP Holdings, Wyeth-Ayers, Vanguard, and Yamanouchi.

Carolinas Research Associates is strategically located in the Piedmont area of North Carolina. The Charlotte metropolitan area spans North and South Carolina, offering a large patient base, a regional medical center and two major hospitals with supporting medical staff and facilities.

Carolinas Research Associates has a broad network of board-certified private practice physicians with experience in a variety of therapeutic areas. We seek the most experienced physicians with a strong desire to become involved in clinical research. Each of our physicians offers access to a diverse patient population.

Carolinas Research Associates was created to provide clinical research services to the pharmaceutical industry by conducting effective and efficient clinical trials in conjunction with our dedicated clinical research coordinators, private practice physicians and study volunteers.

Our management staff provides oversight for all studies, including study budgets, contracts, IRB submissions, and regulatory paperwork, as well as expansion of our physician and study volunteer databases. Our highly trained and experienced staff operates with total medical supervision in every phase of drug trial activity. All study activities are under the direction of a full-time Director of Research. Staff members are trained to provide thorough screening and consenting of all patients to insure candidates that are well qualified for each study.

The population of the Charlotte-Mecklenburg area at present is approximately 2 million. Our patient base covers the Charlotte metropolitan area and spans North and South Carolina. Specifically, our patient base is drawn from physician referrals, patient/family referrals, general public relation activities, local media, newsletters, flyers, and brochures.

To learn more information about Carolinas Research Associates and current studies available please visit our web page at http://www.carolinasresearch.com.

Carolinas Research Associates
4808 Pellyn Farm Court
Charlotte, North Carolina 28226 USA

CenterWatch is listing the following trials that are actively recruiting patients at this center.

• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety Of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, 1-Week, Dose-Comparison Study to Evaluate the Efficacy, Safety, and Tolerability of Colchicine in Patients with an Acute Gout Flare
• A Phase 3, 53 Weeks Study on Analgesic Efficacy and Safety of Naproxcinod: 26-Week, Randomized, Parallel-Group, Double-Blind, Placebo (13 Weeks)- and Naproxen (26 Weeks)- Controlled, Multicenter Study of Naproxcinod (375 mg bid and 750 mg bid) with a 26-Week Naproxen-Controlled Safety Follow-up in Subjects with Osteoarthritis of the Knee, and a 1-Week Post-treatment Safety Follow-up.
• A Phase 3, Randomized, Multicenter, Double-Blind, Allopurinol-Controlled Study Assessing the Efficacy and Safety of Oral Febuxostat in Subjects with Gout
• A Phase III, Open-Label, Long-Term Safety Study of Tramadol Hydrochloride Extended Release and Meloxicam QD Combination in the Treatment of Moderate to Moderately Severe Pain Associated with Osteoarthritis
• A Randomized Double-Blind, Placebo- and Active-Control. Parallel-arm, Phase III Trial with Controlled Adjustment of Dose to Evaluate the Efficacy and Safety of study drug Extended Release (ER) in Subjects with Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
• A Randomized, Double-Blind, Phase 3 Study of the Efficacy and Safety of HZT-501 in Subjects Requiring NSAID Treatment
• A Randomized, Multicenter, Double-blind, Placebo-controlled, Dose-range-finding, Parallel-design, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients with Irritable Bowel Syndrome with Constipation
• A Study of Combination Product (sumatriptan succinate and naproxen sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Eletriptan (Study 1 of 2)
• A Two-Arm, Open-Label, Randomized, Multi-Center Pharmacokinetic and Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate In Hypogonadal Men
• Heartburn / GERD

For more information, please contact:

Yvonne McCracken
Director of Research
Carolinas Research Associates
4808 Pellyn Farm Court
Charlotte, NC 28226 USA
Phone: 704-366-3001
Fax: 704-364-4422
E-mail:

If you are interested in contacting this center to discuss placing a clinical trial there, please complete and send the E-mail form below. A representative from the research center will then follow up with you.

Name:
Address:
City:
State:
Zip:
Phone:
Email address:
Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

Last updated on April 29, 2008

PAC>